Antidepressant-like properties of sarizotan in experimental Parkinsonism.
about
What can rodent models tell us about apathy and associated neuropsychiatric symptoms in Parkinson's disease?Behavioral characterization of the 6-hydroxidopamine model of Parkinson's disease and pharmacological rescuing of non-motor deficits.Cognitive dysfunction and depression in Parkinson's disease: what can be learned from rodent models?Intramolecular carbolithiation of N-allyl-ynamides: an efficient entry to 1,4-dihydropyridines and pyridines - application to a formal synthesis of sarizotan.A progressive dopaminergic phenotype associated with neurotoxic conversion of α-synuclein in BAC-transgenic rats.Aripiprazole, an atypical antipsychotic drug, improves maturation and complexity of neuroblast dendrites in the mouse dentate gyrus via increasing superoxide dismutases.
P2860
Antidepressant-like properties of sarizotan in experimental Parkinsonism.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Antidepressant-like properties of sarizotan in experimental Parkinsonism.
@en
Antidepressant-like properties of sarizotan in experimental Parkinsonism.
@nl
type
label
Antidepressant-like properties of sarizotan in experimental Parkinsonism.
@en
Antidepressant-like properties of sarizotan in experimental Parkinsonism.
@nl
prefLabel
Antidepressant-like properties of sarizotan in experimental Parkinsonism.
@en
Antidepressant-like properties of sarizotan in experimental Parkinsonism.
@nl
P2860
P1433
P1476
Antidepressant-like properties of sarizotan in experimental Parkinsonism.
@en
P2093
Martin Egeland
Xiaoqun Zhang
P2860
P2888
P304
P356
10.1007/S00213-011-2356-7
P577
2011-06-07T00:00:00Z